81.29
+2(+2.52%)
Currency In USD
| Previous Close | 79.29 |
| Open | 78.88 |
| Day High | 82.27 |
| Day Low | 75 |
| 52-Week High | 105 |
| 52-Week Low | 12.55 |
| Volume | 63,436 |
| Average Volume | 55,043 |
| Market Cap | 501.56M |
| PE | -21.17 |
| EPS | -3.84 |
| Moving Average 50 Days | 62.79 |
| Moving Average 200 Days | 43.69 |
| Change | 2 |
If you invested $1000 in Monopar Therapeutics Inc. (MNPR) since IPO date, it would be worth $613.51 as of October 24, 2025 at a share price of $81.29. Whereas If you bought $1000 worth of Monopar Therapeutics Inc. (MNPR) shares 5 years ago, it would be worth $3,251.6 as of October 24, 2025 at a share price of $81.29.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Monopar Announces Abstract Accepted for Oral Presentation at AASLD - The Liver Meeting® 2025
GlobeNewswire Inc.
Oct 15, 2025 12:00 PM GMT
WILMETTE, Ill., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announ
Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire Inc.
Sep 24, 2025 3:08 AM GMT
WILMETTE, Ill., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (“Monopar Therapeutics”, “Monopar”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet m
Monopar Announces Journal of Hepatology Publishes Physicians’ Letter to the Editor Demonstrating ALXN1840 Rapidly Improved Copper Balance in Wilson Disease Patients
GlobeNewswire Inc.
Sep 24, 2025 3:07 AM GMT
WILMETTE, Ill., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today annou